Corteva (NYSE:CTVA) Stock Price Expected to Rise, Argus Analyst Says

Corteva (NYSE:CTVA) had its price target boosted by equities research analysts at Argus from $80.00 to $91.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Argus’ price objective would indicate a potential upside of 8.35% from the company’s current price.

Several other research analysts have also recently commented on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Corteva in a research report on Monday, December 29th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $88.00 price target on shares of Corteva in a report on Thursday, February 5th. Mizuho boosted their price objective on Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 17th. Bank of America increased their price objective on Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a report on Thursday, January 8th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $83.19.

Corteva Stock Performance

CTVA stock opened at $83.99 on Tuesday. Corteva has a 1 year low of $53.40 and a 1 year high of $84.14. The stock has a market capitalization of $56.39 billion, a price-to-earnings ratio of 53.16, a PEG ratio of 2.86 and a beta of 0.72. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The stock’s fifty day moving average is $77.07 and its two-hundred day moving average is $69.88.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company’s quarterly revenue was down 1.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts predict that Corteva will post 2.96 EPS for the current year.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.14% of the company’s stock.

Institutional Investors Weigh In On Corteva

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Chilton Capital Management LLC raised its holdings in shares of Corteva by 18.1% in the 3rd quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock worth $30,119,000 after purchasing an additional 68,380 shares in the last quarter. TriaGen Wealth Management LLC bought a new stake in Corteva during the third quarter worth approximately $4,284,000. Truist Financial Corp grew its position in Corteva by 4.5% in the third quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock worth $21,771,000 after buying an additional 13,910 shares during the last quarter. New York State Teachers Retirement System grew its position in Corteva by 4.5% in the third quarter. New York State Teachers Retirement System now owns 551,389 shares of the company’s stock worth $37,290,000 after buying an additional 23,548 shares during the last quarter. Finally, Alberta Investment Management Corp bought a new position in shares of Corteva in the third quarter valued at $5,018,000. Institutional investors own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.